Holen Sie sich die Stockscreener-App
4.92
0.41%
0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RCEL?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$4.90
Offen:
$4.86
24-Stunden-Volumen:
2,328
Relative Volume:
0.01
Marktkapitalisierung:
$150.40M
Einnahmen:
$50.14M
Nettoeinkommen (Verlust:
$-35.38M
KGV:
-3.5143
EPS:
-1.4
Netto-Cashflow:
$-39.46M
1W Leistung:
-0.81%
1M Leistung:
+28.13%
6M Leistung:
+12.33%
1J Leistung:
-41.22%
1-Tages-Spanne:
$4.86
$4.985
1-Wochen-Bereich:
$4.64
$5.13
52-Wochen-Spanne:
$3.22
$10.29
Avita Medical Inc Stock (RCEL) Company Profile
Firmenname
Avita Medical Inc
Sektor
Branche
Telefon
661-568-1317
Adresse
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.91 | 151.93M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
109.98 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
356.32 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.70 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.33 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-05 | Eingeleitet | Northland Capital | Outperform |
| 2025-11-20 | Hochstufung | BTIG Research | Sell → Neutral |
| 2025-08-08 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-12-24 | Eingeleitet | D. Boral Capital | Buy |
| 2024-04-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-27 | Eingeleitet | BofA Securities | Buy |
| 2020-04-21 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-03 | Eingeleitet | BTIG Research | Buy |
Alle ansehen
Avita Medical Inc Aktie (RCEL) Neueste Nachrichten
Northland Securities Predicts Avita Medical Q1 Earnings - MarketBeat
Growth Recap: Can AVITA Medical Inc maintain sales growthJuly 2025 Pullbacks & Verified Entry Point Signals - baoquankhu1.vn
Avita Medical (NASDAQ:RCEL) Now Covered by Analysts at Northland Securities - MarketBeat
Avita Medical at TD Cowen Conference: Growth and Strategic Focus By Investing.com - Investing.com Canada
RCEL SEC FilingsAvita Medical Inc 10-K, 10-Q, 8-K Forms - Stock Titan
RCELAVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - ADVFN Ltd
RCEL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Retail Trends: Can AVITA Medical Inc weather a recession2025 Trade Ideas & Reliable Momentum Entry Alerts - baoquankhu1.vn
Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Zacks Investment Research
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Avita Medical Targets “Progressive” 2026 Growth, Guides $80M-$85M Revenue After Headwind Year - MarketBeat
Wall Street experts predict Avita Medical (RCEL) may surge by 29.87%: Here’s how you can approach trading - Bitget
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference - Investing News Network
Avita Medical (NASDAQ:RCEL) CFO David O'toole Purchases 3,000 Shares of Stock - MarketBeat
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 earnings call transcript - MSN
AVITA Medical (RCEL) CFO awarded RSU and stock option grants - Stock Titan
Avita Medical (RCEL) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Scar Treatment Market Size is Expected to Reach USD 56.30 Billion by 2033; Growth is Propelling Due to the Surging Awareness for Advanced Cosmetic and Reconstructive Procedures Globally - GlobeNewswire Inc.
RCEL: D. Boral Capital Maintains "Buy" Rating and $10 PT | RCEL Stock News - GuruFocus
Avita Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Broker tips 25% upside for this ASX healthcare stock following FY25 earnings results - MSN
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth - Investing.com Nigeria
Avita Medical Earnings Call Signals Stabilizing Growth - The Globe and Mail
Avita Medical (RCEL) TTM US$48.6m Loss Tests Bullish Profitability Narratives - simplywall.st
Avita's Road to Profitability Is in Sight - Morningstar
AVITA Medical to Host Investor Webinar Briefing - Investing News Network
Ask AVITA Medical’s interim CEO your questions in Feb. 18 investor webinar Q&A - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Avita Medical Q4 2025 slides: 11% annual growth with 12-19% expansion targeted for 2026 - Investing.com Canada
Earnings call transcript: Avita Medical Q4 2025 sees steady revenue growth By Investing.com - Investing.com South Africa
AVITA Medical (RCEL) Reports Strong Q4 2025 Performance - GuruFocus
Avita Medical Q4 Earnings Call Highlights - MarketBeat
AVITA Medical, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
AVITA Medical (RCEL) Q4 2025 Earnings Transcript - The Globe and Mail
RCEL Refines Financial Strategy with New Credit Facility - GuruFocus
Avita Medical (RCEL) Reports Lower Q4 Revenue Amidst Operational Transition - GuruFocus
Avita Medical earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
AVITA Medical to Announce Q4 Earnings on February 12 - Intellectia AI
Avita Medical (NASDAQ:RCEL) Issues Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat
AVITA Medical, Inc. SEC 10-K Report - TradingView
AVITA Medical Q4 Earnings Summary & Key Takeaways - Benzinga
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results - Bluefield Daily Telegraph
Lake Street raises price target on AVITA Medical, Inc. (RCEL) to $3.50, maintains hold rating - MSN
Is AVITA Medical Inc. forming a bullish divergenceEarnings Recap Summary & Fast Entry and Exit Trade Plans - mfd.ru
Bull Run: Can AVITA Medical Inc weather a recessionMarket Performance Summary & Precise Buy Zone Identification - baoquankhu1.vn
Is AVITA Medical Inc. stock a buy before product launchesTrade Risk Report & Fast Exit and Entry Trade Guides - mfd.ru
Aug Volume: What is the dividend yield of GOOSJuly 2025 EndofMonth & Verified Entry Point Signals - baoquankhu1.vn
Lake Street Raises Price Target on AVITA Medical, Inc. (RCEL) to $3.50, Maintains Hold Rating - Finviz
Finanzdaten der Avita Medical Inc-Aktie (RCEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.23%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):